Premium
Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical Checklist
Author(s) -
Yiu Zenas Z.N.,
Warren Richard B.
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.788
Subject(s) - psoriasis , checklist , medicine , quality of life (healthcare) , alternative medicine , dermatology , intensive care medicine , psychology , nursing , pathology , cognitive psychology
The quality of life for a patient has been transformed in the last 15 years due to innovations that have resulted in better treatments for severe psoriasis, a chronic inflammatory cutaneous disease. Now, novel therapies for psoriasis need to reach a high standard in order to offer patients with psoriasis a genuine alternative. Here we outline a suggested critical checklist that will help industry sponsors, researchers, and clinicians evaluate novel therapeutics for psoriasis.